CompaniesRanked

2874 şirket · 2025 mali yılı · SEC EDGAR · 25 Eylül 2026

En çok uzun vadeli borcu olan sağlık şirketleri — sayfa 2

246 şirket arasında 101–200. sıra · 2025 mali yılı · Veri tarihi: 25 Eylül 2026

Uzun vadeli borç
#ŞirketUzun vadeli borçYıllık15 yıllık seyir
101NeogenNEOGUS$793M−%10,9
102Bright Horizons Family SolutionsBFAMUS$748M−%18,6
103Merit Medical SystemsMMSIUS$734M+%0,6
104Integra LifesciencesIARTUS$727M−%4,5
105Sonida Senior LivingSNDAUS$682M+%7,3
106Alnylam PharmaceuticalsALNYUS$676M+%253,3
107Amphastar PharmaceuticalsAMPHUS$620M+%1,0
108Phibro Animal HealthPAHCUS$604M−%3,1
109Edwards LifesciencesEWUS$598M+%0,1
110Biomarin PharmaceuticalBMRNUS$597M—
111ModernaMRNAUS$590M+$590M
112Msa SafetyMSAUS$573M+%18,9
113Emergent BiosolutionsEBSUS$572M−%13,8
114Pediatrix MedicalMDUS$571M−%6,7
115Lantheus HoldingsLNTHUS$569M+%0,6
116Skinhealth SystemsSKINUS$552M—
117RepligenRGENUS$542M+%3,2
118InsmedINSMUS$541M−%51,0
119Curaleaf HoldingsCURLFUS$513M+%9,9
120Alphatec HoldingsATECUS$501M−%12,7
121Sinovac BiotechSVACN$495M+%31,7
122Ascendis PharmaASNDDK$453M+%19,4
123Oscar HealthOSCRUS$430M+%43,6
124Cresco LabsCRLBFUS$417M−%9,5
125ResmedRMDUS$404M−%39,1
126Immunocore HoldingsIMCRGB$403M—
127Telix PharmaceuticalsTLXAU$392M+%14,7
128Porch GroupPRCHUS$385M−%4,6
129Supernus PharmaceuticalsSUPNUS$379M+%1.532,9
130Caris Life SciencesCAIUS$379M+%18,6
131Idexx LaboratoriesIDXXUS$375M−%16,7
132Pacira BiosciencesPCRXUS$372M−%3,0
133MannkindMNKDUS$355M+%883,7
134LivanovaLIVNGB$345M−%37,2
135Madrigal PharmaceuticalsMDGLUS$340M+%189,1
136Alignment HealthcareALHCUS$323M+%0,5
137Tandem Diabetes CareTNDMUS$310M+%0,6
138Ani PharmaceuticalsANIPUS$292M−%5,6
139Ascend WellnessAAWHUS$291M+%35,8
140Cadre HoldingsCDREUS$291M+%37,4
141Indivior PharmaceuticalsINDVUS$290M−%7,9
142Maravai LifesciencesMRVIUS$286M−%1,4
143PTC TherapeuticsPTCTUS$285M+%0,4
144NateraNTRAUS$283M+%0,5
145BioventusBVSUS$279M−%9,5
146Lifestance HealthLFSTUS$266M−%5,0
147Bio-TechneTECHUS$260M−%13,3
148InnovivaINVAUS$258M+%0,6
149HarrowHROWUS$250M−%4,8
150Establishment LabsESTAVG$248M+%12,7
151TG TherapeuticsTGTXUS$246M+%0,5
152Pacs GroupPACSUS$245M−%2,5
153NovavaxNVAXUS$244M—
154P3 Health PartnersPIIIUS$228M+%109,7
155National VisionEYEUS$223M−%6,7
156Xeris BiopharmaXERSUS$220M+%1,5
157ArtivionAORTUS$215M−%31,5
158Phathom PharmaceuticalsPHATUS$209M+%3,8
159Nu Skin EnterprisesNUSUS$204M−%43,8
160ArdelyxARDXUS$203M+%34,5
161West Pharmaceutical ServicesWSTUS$203M+%0,1
162Jushi HoldingsJUSHUS$199M+%8,6
163Ironwood PharmaceuticalsIRWDUS$199M−%50,0
164NovocureNVCR$195M+%100,5
165BiontechBNTXDE$194M−%31,4
166ValnevaVALNFR$189M+%9,5
167Karyopharm TherapeuticsKPTIUS$169M—
168Pennant GroupPNTGUS$169M+$169M
169Canopy GrowthCGCCA$164M−%46,1
170Orthofix MedicalOFIXUS$157M+%0,2
171U S Physical TherapyUSPHUS$153M+%7,1
172Tilray BrandsTLRYUS$152M+%1.509,6
173EvolusEOLSUS$146M+%20,2
174Harmony BiosciencesHRMYUS$144M−%11,9
175Ensign GroupENSGUS$138M−%2,9
176Trulieve CannabisTRLVUS$137M−%62,5
177Adaptive BiotechnologiesADPTUS$127M−%4,4
178AccurayARAYUS$125M−%25,7
179Ufp TechnologiesUFPTUS$123M−%30,5
180Addus HomecareADUSUS$121M−%44,6
181Myriad GeneticsMYGNUS$120M+%202,8
182Axsome TherapeuticsAXSMUS$118M−%34,8
183Arcutis BiotherapeuticsARQTUS$108M+%0,7
184TrupanionTRUPUS$102M−%20,2
185Rhythm PharmaceuticalsRYTMUS$101M−%6,8
186OrthopediatricsKIDSUS$99,8M+%36,8
187Arcus BiosciencesRCUSUS$99,0M+%106,3
188BioteBTMDUS$95,8M−%5,4
189ChemedCHEUS$92,5M−%50,0
190Avanos MedicalAVNSUS$90,3M−%27,9
191Starling OncologySTLNUS$77,4M−%16,9
192XencorXNCRUS$76,5M−%33,6
193MarimedMRMDUS$76,0M−%2,7
194NRC HealthNRCUS$75,0M+%29,6
195Tarsus PharmaceuticalsTARSUS$72,4M+%0,8
196Adma BiologicsADMAUS$69,3M−%4,2
197Glass House BrandsGLASUS$68,6M+%35,8
198HUTCHMED (China)HCMHK$68,2M+%14,7
199Organogenesis HoldingsORGOUS$66,6M−%6,6
200NeuroneticsSTIMUS$65,8M+%19,3

Tüm rakamlar SEC dosyalamalarından · FY2025 · 100

kaynakları gör

Bu veriyi CSV olarak indir →

En çok uzun vadeli borcu olan şirketler →

Sektöre göre

Ülkeye göre